Prof. Xiaobin Wang 王晓彬
Chief Physician, Professor
Gynecology (IV), Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant gynecologic tumors, including cervical, uterine body, ovarian, vulvar, and trophoblastic cancers. Expertise in minimally invasive laparoscopic and vaginal surgeries.
Dr. Wang graduated from China Medical University in 1987 with a master’s degree. Currently Chief of the Third Gynecology Department at Liaoning Cancer Hospital & Institute, Dr. Wang trained at leading institutions including Beijing 301 Hospital. Research includes one Wu Jieping Foundation project and multiple provincial topics. Dr. Wang has published over ten papers in national core journals and one SCI paper.
Professional roles
- Member, Obstetrics and Gynecology Branch, Liaoning Medical Association (Chinese Medical Association)
- Standing Committee Member, Tumor Immunology Professional Committee, Liaoning Immunology Society
- Member, Gynecologic Laparoscopy Professional Committee, Liaoning Anti-Cancer Association
- Member, Tumor Metastasis Professional Committee, Liaoning Anti-Cancer Association
Name order: in Chinese the family name comes first (Wang Xiaobin). Papers usually list the name as Xiaobin Wang or Wang X.
Selected publications
10 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Cell Physiol, 2020 (senior author): TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway. PubMed 31951023
- Oncol Lett, 2019 (senior author): Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients. PubMed 31289467
- Tumour Biol, 2014 (first author): The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer. PubMed 24737583
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion